These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 25934814)

  • 1. Making every drop count for pediatric kidney transplant patients.
    Clark SL; Taylor A; Shaw KN; Copelovitch L
    Hosp Pediatr; 2015 May; 5(5):287-9. PubMed ID: 25934814
    [No Abstract]   [Full Text] [Related]  

  • 2. Limited sampling strategy for estimating individual exposure of tacrolimus in pediatric kidney transplant patients.
    Zhao W; Fakhoury M; Baudouin V; Maisin A; Deschênes G; Jacqz-Aigrain E
    Ther Drug Monit; 2011 Dec; 33(6):681-7. PubMed ID: 22011724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic drug monitoring of once-daily tacrolimus (Advagraf) in a gastrectomized kidney transplant recipient.
    Ma TK; Chow KM; Kwan BC; Leung CB; Szeto CC; Li PK
    Nephrology (Carlton); 2017 Feb; 22(2):184. PubMed ID: 28064453
    [No Abstract]   [Full Text] [Related]  

  • 4. Consideration of the switch from twice-daily to once-daily tacrolimus in pediatric kidney transplant in daily clinical practice: pharmacokinetic parameters, patient satisfaction and medical practices.
    Favennec C; Allain-Launay E; Launay E; Le Grand A; Bertholet-Thomas A; Maisin A; Garnier A; Meriau E; Roussey-Kesler G
    Pediatr Transplant; 2014 Nov; 18(7):777-9. PubMed ID: 25164065
    [No Abstract]   [Full Text] [Related]  

  • 5. Population pharmacokinetics of tacrolimus in adult kidney transplant recipients.
    Staatz CE; Willis C; Taylor PJ; Tett SE
    Clin Pharmacol Ther; 2002 Dec; 72(6):660-9. PubMed ID: 12496747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tacrolimus hydrate (tacrolimus)].
    Matsuda J
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():465-8. PubMed ID: 15658364
    [No Abstract]   [Full Text] [Related]  

  • 7. [The therapeutic drug monitoring network server of tacrolimus for Chinese renal transplant patients].
    Deng CH; Zhang GM; Bi SS; Zhou TY; Lu W
    Yao Xue Xue Bao; 2011 Jul; 46(7):828-33. PubMed ID: 22010353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limited sampling strategies for tacrolimus exposure (AUC0-24) prediction after Prograf(®) and Advagraf(®) administration in children and adolescents with liver or kidney transplants.
    Almeida-Paulo GN; Lubomirov R; Alonso-Sanchez NL; Espinosa-Román L; Fernández Camblor C; Díaz C; Muñoz Bartola G; Carcas-Sansuán AJ
    Transpl Int; 2014 Sep; 27(9):939-48. PubMed ID: 24861353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic drug monitoring of tacrolimus: a moving matter.
    Manzanares C
    Therapie; 2002; 57(2):133-6. PubMed ID: 12185961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacist Impact on Tacrolimus Serum Concentrations in Liver Transplant Patients.
    Schuh MJ; Massoglia G
    Consult Pharm; 2018 May; 33(5):268-272. PubMed ID: 29789048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First clinical experience with the new once-daily formulation of tacrolimus.
    First MR
    Ther Drug Monit; 2008 Apr; 30(2):159-66. PubMed ID: 18367975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sublingual administration of tacrolimus in a renal transplant patient.
    Romero I; Jiménez C; Gil F; Escuin F; Ramirez E; Fudio S; Borobia A; Carcas A
    J Clin Pharm Ther; 2008 Feb; 33(1):87-9. PubMed ID: 18211623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited sampling strategies for once daily tacrolimus exposure monitoring.
    Carcas-Sansuán AJ
    Eur J Clin Pharmacol; 2016 Jun; 72(6):773-4. PubMed ID: 26939899
    [No Abstract]   [Full Text] [Related]  

  • 14. Response: Limited sampling strategies for once daily tacrolimus exposure monitoring.
    Moes DJ; Swen JJ; van der Bent SA; van der Straaten T; Inderson A; Olofsen E; Verspaget HW; Guchelaar HJ; den Hartigh J; van Hoek B
    Eur J Clin Pharmacol; 2016 Jun; 72(6):775-6. PubMed ID: 26931555
    [No Abstract]   [Full Text] [Related]  

  • 15. Dosing and management guidelines for tacrolimus in renal transplant patients.
    van Hooff JP; Boots JM; van Duijnhoven EM; Christiaans MH
    Transplant Proc; 1999 Nov; 31(7A):54S-57S. PubMed ID: 10576046
    [No Abstract]   [Full Text] [Related]  

  • 16. Limited sampling strategies for monitoring tacrolimus in pediatric liver transplant recipients.
    Delaloye JR; Kassir N; Lapeyraque AL; Alvarez F; Lallier M; Beaunoyer M; Labbé L; Théorêt Y; Litalien C
    Ther Drug Monit; 2011 Aug; 33(4):380-6. PubMed ID: 21743386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosing tacrolimus based on CYP3A5 genotype: will it improve clinical outcome?
    van Gelder T; Hesselink DA
    Clin Pharmacol Ther; 2010 Jun; 87(6):640-1. PubMed ID: 20485320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tacrolimus pharmacokinetics in Hispanic children after kidney transplantation.
    Cherala G; Munar MY; Naher A; Al-Uzri A
    Transplant Proc; 2011 Dec; 43(10):3708-12. PubMed ID: 22172831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A switch from conventional twice-daily tacrolimus to once-daily extended-release tacrolimus in stable kidney transplant recipients.
    Hatakeyama S; Fujita T; Yoneyama T; Yoneyama T; Koie T; Hashimoto Y; Saitoh H; Funyu T; Narumi S; Ohyama C
    Transplant Proc; 2012 Jan; 44(1):121-3. PubMed ID: 22310594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of conversion from twice-daily tacrolimus (prograf) to once-daily prolonged-release tacrolimus (graceptor) in stable kidney transplant recipients.
    Nakamura Y; Hama K; Katayama H; Soga A; Toraishi T; Yokoyama T; Kihara Y; Jojima Y; Konno O; Iwamoto H; Takeuchi H; Hirano T; Shimazu M
    Transplant Proc; 2012 Jan; 44(1):124-7. PubMed ID: 22310595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.